Awards

Displaying 1 - 20 of 1906
View All

Brain channelopathies – Target validation and novel therapeutic strategies

MSFHR supported Dr. Terry Snutch’s award as one of five interprovincial teams from across Canada funded through Brain Canada’s Multi-Investigator Research Initiative (MIRI). The MIRI supports the research of multidisciplinary teams and aims to accelerate novel and transformative research that will fundamentally change the understanding of nervous system function and dysfunction and its impact on health. MSFHR committed funding over three years to support the work of Snutch’s BC-based research activities and research led by fellow MIRI recipient Dr. Neil Cashman on the role of protein misfolding in Amyotrophic Lateral Sclerosis (ALS).

Primary Investigator: 
Award Type: 
Year: 
2013

Deliberative public engagement to inform cancer control decision-making in Canada

MSFHR is providing matching funds for Dr. Stuart Peacock’s research through the Canadian Institutes of Health Research Institute of Cancer Control (CIHR-ICR) Partnerships for Health Systems Improvement (PHSI) program. PHSI projects focus on health system improvements through applied and policy-relevant health systems services research that is useful to health system managers or policy-makers and strengthen the Canadian health system.

Primary Investigator: 
Award Type: 
Year: 
2017

Delivery of self-management through a peer-support telehealth intervention in patients with cardiovascular disease: The Healing Circles Project

MSFHR is contributing matched funding for Dr. Scott Lear’s research, one of 22 projects as part of the Canadian Institutes for Health Research (CIHR) eHealth Innovation Partnership Program (eHIPP). eHIPP was designed to address gaps in health care—including supporting seniors with complex care needs in their home—by stimulating collaborations between health researchers and Canadian innovative technology companies. MSFHR is also contributing funds towards the eHIPP research projects of Drs. Ellen Balka and Kendall Ho.

Primary Investigator: 
Award Type: 
Year: 
2015

CCNA Team 13: Frontotemporal dementia

Dr. Robin Hsiung’s research is part of the Canadian Consortium for Neurodegeneration in Aging (CCNA) initiative funded by a national partnership between the Canadian Institutes of Health Research (CIHR) and 14 organizations from the public and private sectors across Canada, including MSFHR. The CCNA was created in 2014, bringing together more than 350 clinicians and researchers from across Canada.

Primary Investigator: 
Award Type: 
Year: 
2015

Silent genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations

MSFHR is providing matching funds for the research of Dr. Laura Arbour under the Genome Canada/ Canadian Institutes for Health Research Large-Scale Applied Research Project (LSARP): Genomics and Precision Health. Additional support is provided by Genome BC, the BC Children's Hospital Foundation, BC Provincial Services Health Authority and the University of British Columbia (UBC).

Primary Investigator: 
Award Type: 
Year: 
2018

TEC4Home: Telehealth for Emergency-Community Continuity of Care Connectivity via Home telemonitoring

MSFHR is contributing matched funding for Dr. Kendall Ho’s research, one of 22 projects funded through the Canadian Institutes for Health Research (CIHR) eHealth Innovation Partnership Program (eHIPP). eHIPP was designed to address gaps in health care—including supporting seniors with complex care needs in their home—by stimulating collaborations between health researchers and Canadian innovative technology companies.The BC Ministry of Health and industry partner TELUS Health are also supporting Ho’s research. MSFHR is also funding the eHIPP research projects of Dr. Ellen Balka and Dr. Scott Lear. In 2017, Ho received a MSFHR Health Professional Investigator Award related to this project.

Primary Investigator: 
Award Type: 
Year: 
2015

Seniors Adding Life to Years (SALTY)

MSFHR is providing matching funds to support the work of a BC team lead by Dr. Kelli Stajduhar as part of the Canadian Institutes of Health Research (CIHR) Team Operating Grant: Late Life Issues initiative. Other funding partners include Nova Scotia Health Research Foundation, Alberta Innovates Health Solutions and Alzheimer Society of Canada.

Primary Investigator: 
Award Type: 
Year: 
2016

Locally produced brain insulin in memory and Alzheimer's disease: A multi-disciplinary approach to a key question

Dr. James Johnson is one of five BC researchers leading teams supported through the British Columbia Alzheimer’s Research Award. Established in 2013 by the Michael Smith Foundation for Health Research (MSFHR), Genome British Columbia (Genome BC), The Pacific Alzheimer Research Foundation (PARF) and Brain Canada, the goal of the $7.5 million fund is to discover the causes of and seek innovative treatments for Alzheimer’s disease and related dementias.

Primary Investigator: 
Award Type: 
Year: 
2015

Novel retinal biomarkers for Alzheimer's disease

Dr. Faisal Beg is one of five BC researchers supported through the British Columbia Alzheimer’s Research Award. Established in 2013 by the Michael Smith Foundation for Health Research (MSFHR), Genome British Columbia (Genome BC), The Pacific Alzheimer Research Foundation (PARF) and Brain Canada, the goal of the $7.5 million fund is to discover the causes of and seek innovative treatments for Alzheimer’s disease and related dementias.

Primary Investigator: 
Award Type: 
Year: 
2015

Diabetic retinopathy screening – National tele-ophthalmology

MSFHR is providing matching funds to support the research of Dr. David Maberley as part of Diabetes Action Canada, one of five national chronic disease networks established through the Canadian Institutes of Health Research’s (CIHR) Strategy for Patient-Oriented Research (SPOR) Networks in Chronic Disease, connecting researchers, health professionals, policy-makers, and patients across the country.

Primary Investigator: 
Award Type: 
Year: 
2016

CHILD-BRIGHT: Child Health Initiatives Limiting Disability – Brain Research Improving Growth and Health Trajectories

MSFHR is providing matching funds to support the research of Dr. Dan Goldowitz as part of CHILD-BRIGHT, one of five national chronic disease networks established through the Canadian Institutes of Health Research’s (CIHR) Strategy for Patient-Oriented Research (SPOR) Networks in Chronic Disease, connecting researchers, health professionals, policy-makers, and patients across the country.

Primary Investigator: 
Award Type: 
Year: 
2016

Validation of connexins and pannexins as a target for Alzheimer's disease

Dr. Christian Naus is one of five BC researchers leading teams supported through the British Columbia Alzheimer’s Research Award. Established in 2013 by the Michael Smith Foundation for Health Research (MSFHR), Genome British Columbia (Genome BC), The Pacific Alzheimer Research Foundation (PARF) and Brain Canada, the goal of the $7.5 million fund is to discover the causes of and seek innovative treatments for Alzheimer’s disease and related dementias.

Primary Investigator: 
Award Type: 
Year: 
2015

Implementing land-based resiliency in First Nations youth: The 'This is Who We Are' Program

Dr. Adrienne Chan’s work is funded through the Canadian Institutes of Health Research (CIHR) Pathways to Health Equity for Aboriginal Peoples Initiative. MSFHR is providing match funding, with additional support provided by the Fraser Health Authority and Vancouver Coastal Health. The goal of the Pathways Initiative is to facilitate research on the design, implementation and scale-up of effective programs and policies that address pressing Aboriginal health issues in four priority areas, including suicide.

Primary Investigator: 
Award Type: 
Year: 
2017

The Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD) Network

MSFHR is providing matching funds to support the research of Dr. Adeera Levin, as part of the Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD) Network, one of five national chronic disease networks established through the Canadian Institutes of Health Research (CIHR) Strategy for Patient-Oriented Research (SPOR) Networks in Chronic Disease, connecting researchers, health professionals, policy-makers, and patients across the country.

Primary Investigator: 
Award Type: 
Year: 
2016

Cellular resolution OCT for clinical ophthalmology

Two of the leading causes of irreversible vision loss in developed countries are age-related macular degeneration (AMD) and diabetic retinopathy (DR). These diseases lead to the death of photoreceptors, the light-sensitive cells in the retina located at the back of the eye.

Treatments are currently available for “wet” AMD and DR, but there are currently no effective treatments for “dry” AMD. The key to preserving sight is early diagnosis, and monitoring the effects of the novel therapies in development.

Primary Investigator: 
Year: 
2018

An advanced wearable robotic exoskeleton for assisting people with lower limb disabilities

Human locomotion is influenced by many factors, including neuromuscular and joint disorders that affect the functionality of joints and can cause partial or complete paralysis. Reduced mobility is estimated to affect over 1.5 million people in the United States alone. Many individuals require mobility assistive technologies to keep up with their daily life, and the demand for these devices increases with age.

Primary Investigator: 
Year: 
2018
Partners: 

AAPLE-Walk: A novel gait-mimicking exercise machine for cardiovascular fitness and rehabilitation

Heart disease and diabetes are just two of many conditions that can occur in people after a spinal cord injury (SCI). Exercise can play a significant role in mitigating the risks associated with these conditions, but typical exercise options for people with SCI or other lower limb disabilities are usually limited to seated upper body exercise (for example, wheeling or hand cycling).

Primary Investigator: 
Year: 
2018

Novel infection resistant coating for indwelling urinary devices

Urinary catheters are polymer tubes inserted into the bladder to drain urine. Over 25% of patients in hospital are fitted with a catheter during their stay. These tubes are a major cause of infection in hospitalized patients and result in longer hospital stays with skyrocketing health care costs and may result in death. In fact, infections acquired in hospitals are the fourth leading cause of death in hospitalized patients. 

Primary Investigator: 
Year: 
2018

Engineered T regulatory cells to treat Crohn's disease

Inflammatory bowel disease (IBD) is an incurable disease that affects about 230,000 Canadians. People with IBD suffer from diarrhea, abdominal pain, weight loss, intestinal blockages, and other complications. Current treatments can control symptoms in many people, but they are not curative, and can have side effects like increased risk of infections. The causes of IBD are so far unknown.

Primary Investigator: 
Year: 
2018

Novel PET imaging agents for prostate cancer detection

Positron emission tomography (PET) imaging provides the most accurate and sensitive detection of cancer in patients. Yet PET is challenged by cumbersome methods that impede the clinical production of PET imaging agents and diminish their distribution and use. A critical unmet need for PET imaging is access to user-friendly methods to simplify and speed up time-sensitive radiosynthesis to deliver imaging agents to clinics.

Primary Investigator: 
Year: 
2018

Pages